ClinOne, BioIntelliSense bring remote monitoring to clinical trials - Business Insider

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 81 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 51%

ایران اخبار اخبار

ایران آخرین اخبار,ایران سرفصلها

The addition of the BioSticker device to ClinOne's platform could speed up drug discovery, making it prime candidate for pharma tie-ups

with continuous health monitoring firm BioIntelliSense to incorporate data generated from the latter's FDA-cleared BioSticker single-use device to ClinOne's ClinTrialConnect patient portal platform.

Through the tie-up, ClinOne will enable researchers to incorporate real-time data on patients' vitals into trials, which can improve the efficacy of treatments. Adding the BioSticker device to the ClinTrialConnect platform provides researchers with 30 days of continuous monitoring of participants' vital sign data, including respiratory rate at rest, heart rate at rest, and skin temperature.

This can be a huge value add to clinical research, considering vital measurements are key to evaluating treatment efficacy, Pharmaceutical Outsourcing: Researchers can leverage the continuous data gathered by the BioSticker device to correlate multiple vital signs and analyze patients' responses to certain treatments.

And considering ClinOne's platform makes it easier for consumers to participate, it could result in a higher retention rate of participants, giving ClinOne a boost in the eyes of potential partners, considering The addition of the BioSticker device to ClinOne's platform could also speed up drug discovery, making it prime candidate for pharma tie-ups.

This can have huge implications on drug discovery by expediting research and limiting development costs: Pharmaceutical companies spend to put a prescription drug through testing and trials, but leveraging real-time data on how participants are reacting to novel drugs could help speed up research — which is likely top of mind for pharmaceutical companies, given it takes an average of Hence, we think the collaboration between ClinOne and BioIntelliSense could make the clinical trial startup a...

 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 729. in İR

ایران آخرین اخبار, ایران سرفصلها

Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.

Business Insider Intelligence - Business InsiderThe article was interesting, but the title... 🤦‍♂️🙅‍♂️ Divorce is never a good thing, it’s never a positive and should not be celebrated. That means one or both parties for whatever reason failed the other. sometimes they don;t even need any promotion at all ! Liberation , freedom is all they need !!
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

PRESENTING: The 31 buzziest logistics startups that VCs are watching in 2020 - Business InsiderRead Business Insider's exclusive, VC-sourced roundup of the buzziest logistics startups in the coming year.
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

SUCCESS INSIDER: Poshmark, college, Bob Iger, Ben & Jerry's - Business InsiderOur regular newsletter for getting things done. Like quitting your full-time job and starting a successful side business. I won't ever be successful because I need to pay your prime membership 🤔 If there was an 11th, it would teach you that unless you lack fundamental business knowledge, you should stop reading business books looking for a formula for success. It doesn't exist. You need to carve your own path / develop your own models. I did without books Maybe with the sky will be the limit
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »

Walmart breaks down how the coronavirus has hit its $10 billion business in China - Business Insider'Our primary focus is of course on our associates and our customers,' Walmart CEO Doug McMillon told investors.
منبع: BusinessInsider - 🏆 729. / 51 ادامه مطلب »